CG Oncology CGON Payments Of Stock Issuance Costs
Payments Of Stock Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's payments of stock issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's payments of stock issuance costs?
- CG Oncology (CGON) reported payments of stock issuance costs of $47K in Q1 2026.
- How has CG Oncology's payments of stock issuance costs changed year-over-year?
- CG Oncology's payments of stock issuance costs decreased by 79.7% year-over-year, from $232K to $47K.
- What does payments of stock issuance costs mean?
- This captures the direct cash costs incurred in connection with raising equity capital, such as underwriting fees, legal expenses, and registration costs. It represents the friction cost of accessing public equity markets. Investors use this to understand the net efficiency of the company's capital-raising activities.